Abstract
We aimed to evaluate the association of Methylenetetrahydrofolate reductase C677T polymorphism with ESCC. We searched MEDLINE, EMBASE and the Chinese Biomedical Database. All the articles searched were independently reviewed and selected by 2 evaluators according to the predetermined criteria. A total of 10 case-control studies published between 2001 and 2011 were included. When all the studies were pooled, the crude odds ratio (95% CI) of ESCC forindividuals carrying MTHFR 677 CT and TT genotype were 1.70 (1.32 to 2.20) and 2.10 (1.58 to 2.79), respectively. An Egger’s test provided that the effect estimates were not related to study size (p values for MTHFR 677 CT and TT were 0.16 and 0.17, respectively). The meta-analysis provides evidence that MTHFR 677CT/TTplays a carcinogenic role in ESCC, and its effect is modified by alcohol, tobacco and ethnicity. Key words: Methylenetetrahydrofolate reductase C677T, polymorphism, esophageal cancer, meta-analysis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.